Submit an abstract for the ASH® Meeting on Lymphoma Biology. The deadline to submit is April 29, 2014, at 11:59 p.m. PDT.
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research
The American Society of Hematology (ASH) leads the world in promoting and supporting clinical and scientific hematology research through its many innovative award programs, meetings, publications, and advocacy efforts.
Blood is the official journal of the American Society of Hematology and the most cited peer-reviewed publication in the field. It is published weekly every Thursday, except for the last week in December, in addition to the ASH Annual Meeting Abstracts issue in November.
Explore programs offered by ASH to support clinical and scientific hematology research
ASH's strategic plan highlighting the importance of placing hematology as a top funding priority in the healthcare community
Dr. Pete Lollar reviews a study in which the authors have identified a defense mechanism in which FX enhances virus survival by inhibiting attack by natural antibodies and complement.
Dr. Bethany Samuelson and Dr. David Garcia review three sufficiently powered clinical studies that are designed to test whether genotype-guided dosing improves TTR or clinical outcomes have been lacking.
Dr. Mark Koury reviews a study that demonstrates, in short-term, the fibroblast-like interstitial cells that produce the majority of erythropoietin in the body are not destroyed as a consequence of renal inflammation, but rather they are
transformed into myofibroblasts that cause fibrosis and scarring in chronic kidney disease.
Dr. Mark Chao and Dr. Jason Gotlib review two studies unearth another highly recurrent mutation in MPN patients, eight years after the discovery of JAK2 V617F.
On February 6, 2014 the leadership of the House Ways and Means and Energy and Commerce Committees and the Senate Finance Committee released a bi-partisan and bicameral bill to repeal the Sustainable Growth Rate (SGR) formula that has driven annual reductions in Medicare payment for physician services.
On Thursday, December 26, President Obama signed the Bipartisan Budget Act of 2013 (BBA). This agreement included the Pathway for SGR Reform Act of 2013, a provision of the budget framework which prevents the scheduled Medicare payment reduction from taking effect on January 1, 2014 and provides for a 0.5 percent increase for Medicare payments for services performed from January 1, 2014 through March 31, 2014.
On December 12, 2013 the House Ways and Means Committee and the Senate Finance Committee passed similar bills to repeal the Sustainable Growth Rate (SGR) formula that drives annual reductions in Medicare payment for physician services.
President Obama has announced the nomination of Vivek Hallegere Murthy, MD, MBA, to be the next U.S. Surgeon General.
Welcome to “This Week in Blood,” a weekly snapshot of the hottest studies from each week’s issue of Blood, the official journal of the American Society of Hematology (ASH), hand-picked by Blood Editor-in-Chief Bob Löwenberg, MD, PhD, and Deputy Editor Nancy Berliner, MD. If you would like a PDF copy of any of the manuscripts highlighted below or would like to request an interview with the author, please email firstname.lastname@example.org.
August 10-13, 2014 The Broadmoor, Colorado Springs, Colorado
Participate in a scientific forum for basic and translational research in lymphoma and lymphoid malignancies.
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology